Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of Landiolol in Patients Scheduled for Coronary Angiography
NCT00560209Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of landiolol in coronary artery disease (CAD), sponsored by Ono Pharmaceutical. Started Nov 2007; status: completed.
02
Drugs
landiolol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00560209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00560209.